Literature DB >> 20391506

After patients are diagnosed with knee osteoarthritis, what do they do?

Kelly A Grindrod1, Carlo A Marra, Lindsey Colley, Jolanda Cibere, Ross T Tsuyuki, John M Esdaile, Louise Gastonguay, Jacek Kopec.   

Abstract

OBJECTIVE: To learn more about the health services and products that patients use after receiving a diagnosis of knee osteoarthritis (OA), as well as the trajectory of their health-related quality of life (HRQOL).
METHODS: Using a simple screening survey, community pharmacists identified 194 participants with previously undiagnosed knee OA. Of these participants, 190 were confirmed to have OA on further investigation. At baseline and 1, 3, and 6 months after diagnosis, a survey was administered to assess health services, product use, and HRQOL, including the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Medical Outcomes Study Short Form 36 (SF-36) health survey, the Paper Adaptive Test (PAT-5D-QOL), and the Health Utilities Index Mark 3.
RESULTS: With a mean age of 63 years, participants were mostly women, white, and overweight. By 6 months, more than 90% of the participants had visited their family physician to discuss their OA, and more than 50% of participants took either prescription or nonprescription analgesics. In addition, three-quarters of the participants started exercising, one-third initiated activity aids, and one-third had started natural medicine products. At 6 months compared with baseline, significant improvements were seen in the SF-36 physical component summary (P = 0.001) and bodily pain domain scores (P = 0.02), the PAT-5D-QOL overall, pain, and usual daily activities scores (P < 0.001 for all), and the WOMAC total, pain, and function scores (P < 0.001 for all).
CONCLUSION: Within 6 months of receiving a diagnosis of knee OA, participants made several lifestyle interventions, often without the advice of a health professional, and saw improvements in their pain and function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20391506     DOI: 10.1002/acr.20170

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  12 in total

1.  Early knee osteoarthritis prevalence is highest among middle-aged adult females with obesity based on new set of diagnostic criteria from a large sample cohort study in the Japanese general population.

Authors:  Eiji Sasaki; Seiya Ota; Daisuke Chiba; Yuka Kimura; Shizuka Sasaki; Yuji Yamamoto; Eiichi Tsuda; Shigeyuki Nakaji; Yasuyuki Ishibashi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-07-10       Impact factor: 4.342

2.  Practice guidelines for pharmacists: The management of osteoarthritis.

Authors:  Jason Kielly; Erin M Davis; Carlo Marra
Journal:  Can Pharm J (Ott)       Date:  2017-05-01

3.  Clinician's Commentary on Winter Di Cola et al.(1.).

Authors:  Linda Li
Journal:  Physiother Can       Date:  2014       Impact factor: 1.037

4.  Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty.

Authors:  Elena Losina; A David Paltiel; Alexander M Weinstein; Edward Yelin; David J Hunter; Stephanie P Chen; Kristina Klara; Lisa G Suter; Daniel H Solomon; Sara A Burbine; Rochelle P Walensky; Jeffrey N Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-02       Impact factor: 4.794

5.  Perception and presentation of function in patients with unilateral versus bilateral knee osteoarthritis.

Authors:  Adam R Marmon; Joseph A Zeni; Lynn Snyder-Mackler
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

6.  Daily symptom management practices for arthritis used by older adults.

Authors:  Sara A Quandt; Joseph G Grzywacz; Rebecca H Neiberg; Wei Lang; Kathryn Altizer; Ronny A Bell; Thomas A Arcury
Journal:  J Aging Health       Date:  2011-12-14

7.  Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?

Authors:  E Losina; M E Daigle; L G Suter; D J Hunter; D H Solomon; R P Walensky; J M Jordan; S A Burbine; A D Paltiel; J N Katz
Journal:  Osteoarthritis Cartilage       Date:  2013-02-04       Impact factor: 6.576

Review 8.  Future perspectives of Smartphone applications for rheumatic diseases self-management.

Authors:  Ana Rita Pereira Azevedo; Hugo Manuel Lopes de Sousa; Joaquim António Faria Monteiro; Aurea Rosa Nunes Pereira Lima
Journal:  Rheumatol Int       Date:  2014-08-29       Impact factor: 2.631

9.  Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation.

Authors:  E Losina; I M Usiskin; S R Smith; J K Sullivan; K C Smith; D J Hunter; S P Messier; A D Paltiel; J N Katz
Journal:  Osteoarthritis Cartilage       Date:  2018-03-02       Impact factor: 6.576

10.  Longitudinal use of complementary and alternative medicine among older adults with radiographic knee osteoarthritis.

Authors:  Shibing Yang; Catherine E Dubé; Charles B Eaton; Timothy E McAlindon; Kate L Lapane
Journal:  Clin Ther       Date:  2013-10-18       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.